| Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
|---|
| 12/18/2013 | CN102304104B TRPV1 (transient receptor potential cation channel, subfamily V, member 1) antagonists, and preparation method and medical application thereof |
| 12/18/2013 | CN102295621B Morpholine modified para-tert-butyl phenolic resin and preparation method thereof |
| 12/17/2013 | US8609892 Glucagon receptor antagonists, preparation and therapeutic uses |
| 12/17/2013 | US8609839 Camphor-derived compounds, method for manufacturing the same, and application thereof |
| 12/17/2013 | US8609665 Solvate and crystalline forms of carbamoyl-cyclohexane derivatives |
| 12/17/2013 | US8609664 Piperazinyl derivatives as modulators of chemokine receptor activity |
| 12/17/2013 | CA2703444C Low molecular weight quaternary ammonium salt dispersants |
| 12/12/2013 | WO2013184202A1 Fbxo3 inhibitors |
| 12/12/2013 | WO2013183490A1 Electrolyte, method for manufacturing ester compound included in same, and lithium secondary cell |
| 12/12/2013 | WO2013182991A1 Method for preparing methylated amines |
| 12/12/2013 | WO2013182468A1 Piperazine preparation method |
| 12/12/2013 | WO2013182465A1 Piperazine preparation method |
| 12/12/2013 | US20130331574 Process for Preparing Piperazine |
| 12/12/2013 | US20130331396 Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase |
| 12/12/2013 | US20130331392 Cycloalkyl guanidine f1f0-atpase inhibitors and therapeutic uses thereof |
| 12/12/2013 | CA2875305A1 Fbxo3 inhibitors |
| 12/11/2013 | CN103435575A Preparation method of 1-(3-(3-(4-chlorphenyl) propoxy) propyl) piperidine hydrochloride |
| 12/11/2013 | CN103435553A Piperazine structure-based aryl formamide Raf kinase inhibitor and preparation method as well as application thereof |
| 12/11/2013 | CN103435514A Matrix metalloproteinase inhibitor and purpose thereof |
| 12/11/2013 | CN103435430A Method for reducing amide compounds |
| 12/11/2013 | CN103433050A Preparation method of catalyst for synthesizing piperazine through monoethanolamine catalytic amination one-step method |
| 12/11/2013 | CN102702052B Novel diamine-containing farnesyl thiosalicylic acid derivative and preparation method and medicinal application thereof |
| 12/11/2013 | CN101906085B Compound and composition for treating cardiovascular and cerebrovascular diseases and preparation method and use thereof |
| 12/10/2013 | US8603241 Integrally waterproofed concrete |
| 12/10/2013 | CA2656851C Substituted cinnamoyl anthranilate compounds exhibiting anti-fibrotic activity |
| 12/10/2013 | CA2600904C Trifluoromethylbenzamide derivatives and therapeutic uses thereof |
| 12/05/2013 | WO2013181451A1 Treatment of multiple sclerosis and psoriasis using prodrugs of methyl hydrogen fumarate |
| 12/05/2013 | WO2013178810A1 Ornithine- and lysine-derivatives for the treatment of pain |
| 12/05/2013 | WO2013178693A1 Method for producing a mono-n-alkyl piperazine |
| 12/05/2013 | WO2013178534A1 Method for producing a mono-n-alkyl piperazine |
| 12/05/2013 | US20130324732 Process for the Preparation of a Mono-N-Alkypiperazine |
| 12/05/2013 | US20130324731 Process for the preparation of a mono-n-alkylpiperazine |
| 12/05/2013 | US20130324717 Copolymerizable methine and anthraquinone compounds and articles containing them |
| 12/05/2013 | US20130324556 Protease Activated Receptor 2 (PAR2) Antagonists |
| 12/05/2013 | US20130324555 Method of use of pharmaceutical formulations for the treatment of apicomplexan diseases in animals |
| 12/05/2013 | US20130324540 Use of glutaric acid derivatives or the pharmaceutically acceptable salts thereof as anti-arrhythmic agents |
| 12/05/2013 | US20130324539 Treatment of Multiple Sclerosis and Psoriasis Using Prodrugs of Methyl Hydrogen Fumarate |
| 12/04/2013 | EP2669339A1 Novel compound, dye and colored photosensitive composition |
| 12/04/2013 | EP2669276A1 Ornithine- and lysine-derivatives for the treatment of pain |
| 12/04/2013 | EP2668157A1 Protease activated receptor 2 (par2) antagonists |
| 12/04/2013 | EP2489350B1 N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors |
| 12/04/2013 | CN1989106B N-羟基酰胺衍生物及其应用 N- hydroxyamide derivatives and their Applications |
| 12/04/2013 | CN103420944A Method for synthesizing cis-hydronopyl formamide compounds |
| 12/04/2013 | CN103420943A 4-((4-(2, 3, 4-trimethoxy-benzyl)piperazine-1-yl)methyl)-3-nitro-benzoyl guanidine tartrate |
| 12/04/2013 | CN103420942A Compound with dual inhibitory activities to acetylcholine esterase and cholinesterase |
| 12/04/2013 | CN103420941A 2-methoxyphenyl-dimethylamino formic ether derivative and preparation method and application thereof |
| 12/04/2013 | CN103420940A Aralkyl naphthenic aminopiperazine derivatives and applications thereof as multi-targeted antidepressant |
| 12/04/2013 | CN103420939A Method for synthesizing azacycloheptane |
| 12/04/2013 | CN103420938A Method for recovering piperazine after piperazine condensation reaction in quinolone medicine preparation |
| 12/04/2013 | CN103420906A Novel tyrosine protein kinase inhibitor |
| 12/04/2013 | CN103420898A Diaryl piperidine derivatives and applications thereof as multiple-target-point antidepressants |
| 12/04/2013 | CN103420877A Selective hydroxamate-based MMP inhibitors |
| 12/04/2013 | CN103418438A Nitrogen-impurity carbene-class palladium catalyst and preparation method and application thereof |
| 12/04/2013 | CN102532062B Benzoyl urea compound and synthesis method thereof |
| 12/04/2013 | CN101466665B Compositions useful as inhibitors of voltage-gated sodium channels |
| 12/03/2013 | US8598348 Purification of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine |
| 12/03/2013 | CA2599411C Enzyme inhibitors |
| 12/03/2013 | CA2530302C Novel aminobenzophenone compounds |
| 11/28/2013 | WO2013174736A1 N-[3-(2-carboxyethyl)phenyl]piperidin-1-ylacetamide derivatives and use thereof as activators of soluble guanylate cyclase |
| 11/28/2013 | US20130317027 Compounds and therapeutic uses thereof |
| 11/28/2013 | US20130317001 N-substituted benzamides and methods of use thereof |
| 11/28/2013 | US20130317000 N-substituted benzamides and methods of use thereof |
| 11/28/2013 | US20130316907 Process for preparation of herbicidal salts |
| 11/28/2013 | US20130316248 Process for the preparation of compounds containing perfluoroalkanesulfonic acid groups |
| 11/28/2013 | DE102012208530A1 Substituierte Piperidinoacetamide und ihre Verwendung Substituted Piperidinoacetamide and their use |
| 11/27/2013 | EP2666481A2 Method of regulating phosphorylation of sr protein and antiviral agents comprising sr protein activity regulator as the active ingredient |
| 11/27/2013 | CN103408483A Calcium ion channels antagonist manidipine preparation method |
| 11/27/2013 | CN103408433A Method for synthesizing propargylamine compounds |
| 11/27/2013 | CN103406148A Novel acenaphthene imidazole azacyclo-carbenoid allyl palladium chloride compound as well as preparation method and application thereof |
| 11/27/2013 | CN102617391B Resveratrol benzene acrylamide derivative, preparing method and application thereof |
| 11/27/2013 | CN102432842B Ionic liquid-modified conjugate oligomer as well as preparation method and application thereof |
| 11/27/2013 | CN102417489B Setastine hydrochloride crystal form F and preparation method thereof |
| 11/27/2013 | CN102229583B Method for synthesizing cinepazide |
| 11/27/2013 | CN101516830B Method for continuous separation by distillation of mixtures that contain morpholine (MO), monoaminodiglycol (ADG), ammonia and water |
| 11/26/2013 | US8592587 Transannular rearrangement of activated lactams |
| 11/26/2013 | US8592584 Compositions and methods including cell death inducers and procaspase activation |
| 11/26/2013 | US8592578 Process for preparing 2-(aminomethylidene)-4,4-difluoro-3-oxobutyric esters |
| 11/26/2013 | US8592454 Nitrogen-containing heterocyclic compound and use of same |
| 11/26/2013 | US8592432 Compounds and compositions as protein kinase inhibitors |
| 11/26/2013 | US8592419 Ceramides and apoptosis-signaling ligand |
| 11/26/2013 | CA2759399C Inhibitors of the renal outer medullary potassium channel |
| 11/26/2013 | CA2585615C Dicarboxamide derivatives and their use as factor xa inhibitors |
| 11/21/2013 | WO2013172239A1 Acid diffusion control agent, radiation-sensitive resin composition, method for forming resist pattern, compound, and method for producing compound |
| 11/21/2013 | WO2013170859A2 Novel polymeric photoinitiators and photoinitiator monomers |
| 11/21/2013 | US20130310560 Processes for preparing amines and catalysts for use therein |
| 11/21/2013 | US20130310559 Isoprenyl compounds and methods thereof |
| 11/21/2013 | US20130310558 Synthesis, structure and use of functionalized naphthalenes |
| 11/21/2013 | US20130310388 Modulators of TNF-Alpha Signaling |
| 11/21/2013 | US20130310384 Sulfonamide-Containing Compounds |
| 11/21/2013 | US20130310382 P53 activating compounds |
| 11/21/2013 | US20130310320 Boronic ester and acid compounds, synthesis and uses |
| 11/20/2013 | EP2664331A1 Novel Antibacterial Agents |
| 11/20/2013 | EP2356095B1 Methods of making cyclic, n-amino functional triamines |
| 11/20/2013 | EP1540037B1 Organic salts and their use as reagents in electrochemical reactions |
| 11/20/2013 | CN103403018A Trypsin-like serine protease inhibitors, their preparation and use as selective inhibitors of the clotting factors IIa and Xa |
| 11/20/2013 | CN103402986A Modulators of S1P receptors |
| 11/20/2013 | CN103402977A Ingenol-3-acylates III and ingenol-3-carbamates |
| 11/20/2013 | CN103396402A Substituted aminoindanes and analogs thereof, and pharmaceutical use thereof |
| 11/20/2013 | CN103396382A Preparation method of quetiapine intermediate |
| 11/20/2013 | CN103396329A Method for preparing beta-perfluoroalkyl enaminoketone |